The Journal of Clinical Psychiatry has a new feature:
Dr. Marlene Freeman is Editor-in-Chief of The Journal of Clinical Psychiatry and a professor of psychiatry at Harvard Medical School. She serves as Associate Director of the Center for Women’s Mental Health at Massachusetts General Hospital, where she holds the Abra Prentice Foundation Chair in Women’s Mental Health. Dr. Freeman is Medical Director of the Clinical Trials Network and Institute at Mass General and is a Fellow of both the American College of Neuropsychopharmacology and the American Society for Clinical Psychopharmacology.
Key Topics Discussed
- Dr. Freeman’s vision for JCP’s mission and editorial leadership
- Navigating peer review: guidance for authors and reviewers in psychiatric publishing
- Supporting shared decision-making and collaborative patient care in psychiatry
- Balancing scientific rigor with clinical applicability in research
- Emerging trends shaping psychiatric research, treatment, and publication
- JCP’s evolution: specialty sections, digital expansion, and credibility in the modern landscape
- The role of industry research, AI, and preprints in advancing psychiatric science
Episode Overview
In its inaugural episode, the JCP Podcast features a foundational conversation with Dr. Marlene Freeman, Editor-in-Chief of The Journal of Clinical Psychiatry, in which she discusses the journal’s core mission to empower busy mental health professionals with cutting-edge, evidence-based research. Providing insights into academic publishing, from the peer review process to the journal’s vision for psychiatric education, today’s discussion offers essential listening for those at the intersection of clinical practice and scientific discovery.
Dr. Freeman details her professional journey into women’s mental health and perinatal psychiatry, and goes on to explore how the journal balances scientific rigor with clinical relevance to support shared decision-making in patient care. Navigating the complex publication landscape, the episode addresses industry-sponsored studies, the importance of diverse voices, and emerging trends like digital therapeutics, biomarkers, and the potential impact of artificial intelligence on psychiatric research.
